FDA — authorised 29 January 1974
- Application: ANDA083943
- Marketing authorisation holder: DELCOR ASSET CORP
- Local brand name: KENALOG
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Triamcinolonacetonid in United States
FDA authorised Triamcinolonacetonid on 29 January 1974
Marketing authorisations
FDA — authorised 29 January 1974
- Application: ANDA083944
- Marketing authorisation holder: DELCOR ASSET CORP
- Local brand name: KENALOG
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 11 October 1974
- Application: NDA012104
- Marketing authorisation holder: SUN PHARM INDS INC
- Local brand name: KENALOG
- Indication: SPRAY — TOPICAL
- Status: approved
FDA
- Application: NDA011602
- Marketing authorisation holder: DELCOR ASSET CORP
- Local brand name: KENALOG
- Indication: LOTION — TOPICAL
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Triamcinolonacetonid approved in United States?
Yes. FDA authorised it on 29 January 1974; FDA authorised it on 29 January 1974; FDA authorised it on 11 October 1974.
Who is the marketing authorisation holder for Triamcinolonacetonid in United States?
DELCOR ASSET CORP holds the US marketing authorisation.